Nefrologia

Urolitíase: apresentações, avaliação, tratamento e prescrições em departamentos de emergência.

19 Out, 2021 | 12:39h

Urolithiasis: ED Presentations, Evaluation, Management, and Disposition – emDocs

---

Tratamento do diabetes melito em pacientes com doença renal crônica: Core Curriculum 2022.

18 Out, 2021 | 08:47h

Management of Diabetes Mellitus in Patients With CKD: Core Curriculum 2022 – American Journal of Kidney Diseases

---

Hemodiálise em casa: currículo principal 2021.

14 Out, 2021 | 10:44h

Home Hemodialysis: Core Curriculum 2021 – American Journal of Kidney Diseases

 

Comentário no Twitter

Nephrologists and dialysis providers must embrace new technologies and improve their understanding of home hemodialysis systems. Review the benefits, pitfalls, and challenges of HHD in this Core Curriculum by @ScottDBieber and Bessie Young:https://t.co/TAPiH4wSIA (FREE) pic.twitter.com/dgeX0XKiuL

— AJKD (@AJKDonline) October 5, 2021

 

---

Diretriz de consenso | Tratamento da hiperpotassemia no departamento de emergência.

13 Out, 2021 | 13:23h

Hyperkalemia management in the emergency department: An expert panel consensus – Journal of the American College of Emergency Physicians Open

Conteúdo relacionado: Review: Clinical Management of Hyperkalemia. Classification and monitoring, when to reinitiate RAASi therapy, use oral K+-binding agents, and more

Podcast: Hyperkalemia, Diet, K+ Binders, Exercise

Hyperkalemia: Pathophysiology, Risk Factors and Consequence

Hyperkalemia: Pathophysiology, Risk Factors and Consequence (vários artigos)

---

Estudo sugere que um intervalo de 30 segundos entre aferições automatizadas de pressão arterial em consultório é tão acurado e confiável quanto um intervalo de 60 segundos.

8 Out, 2021 | 12:12h

Impact of 30- Versus 60-Second Time Intervals Between Automated Office Blood Pressure Measurements on Measured Blood Pressure – Hypertension (link para o resumo – $ para o texto completo)

 

Comentário no Twitter

Guidelines recommend a 60-sec pause between automated office BP measures. This study indicates a 30-sec interval not only saves time but is just as accurate and reliable. @spjuraschek @therealaishak @TimAndersonMD @jenniferlcluett https://t.co/A77bvhatZq pic.twitter.com/wdrUqZDWs4

— Hypertension (@HyperAHA) October 7, 2021

 

---

Teste genético no diagnóstico de doença renal crônica: recomendações para a prática clínica.

8 Out, 2021 | 11:36h

Genetic testing in the diagnosis of chronic kidney disease: recommendations for clinical practice – Nephrology Dialysis Transplantation

 

Comentário no Twitter

The diagnostic yield of genome sequencing in patients with chronic kidney disease is about 30% in children and 15-20% in adults. Should it be performed in clinical practice? @knoers and coauthors provide an informative review and recommendations. https://t.co/Pzwl0ztTLU pic.twitter.com/tWbko9mOyK

— Muin J. Khoury (@MuinJKhoury) July 23, 2021

 

---

Tratamento com imunossupressão de longo prazo: oportunidades e incertezas.

8 Out, 2021 | 11:35h

Long-Term Immunosuppression Management: Opportunities and Uncertainties – Clinical Journal of the American Society of Nephrology

 

Comentário no Twitter

Long-Term Immunosuppression Management: Opportunities and Uncertainties. A Review evaluates the current state of maintenance immunosuppression in kidney transplant recipients and discusses areas of opportunity and uncertainty in their long-term use. https://t.co/8yWp4PVD7t

— CJASN (@CJASN) August 16, 2021

 

---

Nefrotoxicidade dos medicamentos para tratamento de câncer: foco nos novos agentes.

8 Out, 2021 | 11:33h

Nephrotoxicity of cancer therapeutic drugs: Focusing on novel agents – Kidney Research and Clinical Practice

---

Estudo de coorte | Adicionar um novo anti-hipertensivo a regimes já existentes está associado a maiores reduções na pressão arterial do que o aumento da dose do medicamento inicial.

8 Out, 2021 | 11:14h

Adding a New Medication Versus Maximizing Dose to Intensify Hypertension Treatment in Older Adults: A Prospective Observational Study – Annals of Internal Medicine

Comunicado de imprensa: When blood pressure needs more control, what’s better: An additional drug or more of the same? – Michigan Medicine

Comentário: Adding an antihypertensive to existing regimens associated with greater BP reduction than maximizing dose, with some caveats in adherence – ACP Internist

Conteúdo relacionado: #ESCCongress – RCT: Initial hypertension treatment with a single pill with 4 drugs at quarter doses (irbesartan 37.5 mg, amlodipine 1.25 mg, indapamide 0.625 mg, and bisoprolol 2.5 mg) achieved better BP lowering vs. standard monotherapy (irbesartan 150 mg).

 

Comentário no Twitter (fio – clique para saber mais)

Excited to see our paper in Annals today looking at blood pressure control regiments by adding multiple low dose meds vs. maxing dose then starting new meds. 🧵 https://t.co/3d4L2nZO4v

— Jeremy Sussman (@JeremySussman) October 5, 2021

 

---

No fim das contas, o sal faz bem? Evidências dizem que não.

8 Out, 2021 | 11:00h

Is salt good for you after all? The evidence says no – The Conversation

Conteúdos relacionados:

#ESCCongress – Cluster RCT: Among patients at increased risk for stroke, salt substitution (75% sodium chloride and 25% potassium chloride by mass) reduced the rates of stroke, major cardiovascular events, and death from any cause.

Systematic Review: Altered dietary salt intake for people with chronic kidney disease.

New WHO benchmarks help countries reduce salt intake and save lives.

RCT: Reduced-sodium added-potassium salt substitute reduces blood pressure in hypertensive patients

Potassium Enriched Salt Substitution Could Prevent a Large Number of Cardiovascular Deaths

Meta-Analysis: Effect of Reduction in Dietary Sodium on Blood Pressure Levels

Cluster Randomized Trial: Effect of Salt Substitution on Community-wide Blood Pressure and Hypertension Incidence

---